Cargando…
Genomics of Postprandial Lipidomics in the Genetics of Lipid-Lowering Drugs and Diet Network Study
Postprandial lipemia (PPL) is an important risk factor for cardiovascular disease. Inter-individual variation in the dietary response to a meal is known to be influenced by genetic factors, yet genes that dictate variation in postprandial lipids are not completely characterized. Genetic studies of t...
Autores principales: | Irvin, Marguerite R., Montasser, May E., Kind, Tobias, Fan, Sili, Barupal, Dinesh K., Patki, Amit, Tanner, Rikki M., Armstrong, Nicole D., Ryan, Kathleen A., Claas, Steven A., O’Connell, Jeffrey R., Tiwari, Hemant K., Arnett, Donna K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617762/ https://www.ncbi.nlm.nih.gov/pubmed/34836252 http://dx.doi.org/10.3390/nu13114000 |
Ejemplares similares
-
A lipidome-wide association study of the lipoprotein insulin resistance index
por: Bagheri, Minoo, et al.
Publicado: (2020) -
An Amish founder population reveals rare-population genetic determinants of the human lipidome
por: Montasser, May E., et al.
Publicado: (2022) -
A 6-CpG validated methylation risk score model for metabolic syndrome: The HyperGEN and GOLDN studies
por: Hidalgo, Bertha A., et al.
Publicado: (2021) -
Genomics of Post-Prandial Lipidomic Phenotypes in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study
por: Irvin, Marguerite R., et al.
Publicado: (2014) -
Age and sex are associated with the plasma lipidome: findings from the GOLDN study
por: Slade, Emily, et al.
Publicado: (2021)